Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center